Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab for acute pancreatitis
ISRCTN16935761Phase 2Recruiting
- Sponsor
- University of Liverpool
- Start
- Jun 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 2, randomised, double-blind trial of infliximab in acute pancreatitis (AP) (3 arms), sponsored by University of Liverpool. Started Jun 2019; status: recruiting.
02
Drugs
infliximab
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on ISRCTN16935761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN16935761.